Stoke Therapeutics
STOK
STOK
64 hedge funds and large institutions have $948M invested in Stoke Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
21% more funds holding
Funds holding: 53 → 64 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
64
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.51M | |
| 2 | +$5.59M | |
| 3 | +$5.35M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$4.98M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.15M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$2.55M | |
| 3 | -$2.5M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$729K |